Foyston Gordon & Payne Inc Has $23.24 Million Position in UnitedHealth Group Incorporated $UNH

Key Points

• Foyston Gordon & Payne Inc increased its stake in UnitedHealth Group by 47.4% in the first quarter, bringing its total to 44,365 shares worth approximately $23.2 million.
• UnitedHealth Group reported a quarterly revenue of $111.62 billion, slightly below analysts' expectations, with earnings per share (EPS) of $4.08, missing the consensus estimate by $0.37.
• The company announced a quarterly dividend of $2.21 per share, resulting in an annualized yield of 2.9% as the firm maintains a 38.3% dividend payout ratio.

Foyston Gordon & Payne Inc lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 47.4% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 44,365 shares of the healthcare conglomerate's stock after purchasing an additional 14,271 shares during the quarter. UnitedHealth Group accounts for about 5.7% of Foyston Gordon & Payne Inc's holdings, making the stock its 4th largest position. Foyston Gordon & Payne Inc's holdings in UnitedHealth Group were worth $23,236,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Marshall & Sterling Wealth Advisors Inc. purchased a new position in UnitedHealth Group during the fourth quarter worth about $26,000. Bayforest Capital Ltd boosted its holdings in shares of UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after purchasing an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd increased its position in shares of UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after purchasing an additional 50 shares during the last quarter. IAG Wealth Partners LLC bought a new position in shares of UnitedHealth Group during the 1st quarter valued at about $42,000. Finally, Kapitalo Investimentos Ltda purchased a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $41,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In related news, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the transaction, the chief executive officer owned 10,398 shares of the company's stock, valued at $3,171,390. This trade represents a 5.36% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.28% of the company's stock.

UnitedHealth Group Trading Down 1.5%

Shares of NYSE:UNH traded down $4.72 on Tuesday, hitting $303.77. The company had a trading volume of 22,226,972 shares, compared to its average volume of 23,411,996. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The firm has a market capitalization of $275.12 billion, a price-to-earnings ratio of 13.16, a P/E/G ratio of 1.99 and a beta of 0.43. The firm's 50-day simple moving average is $289.03 and its two-hundred day simple moving average is $394.17. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same period in the prior year, the company posted $6.80 EPS. The firm's revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be given a $2.21 dividend. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.9%. UnitedHealth Group's dividend payout ratio is currently 38.30%.

Wall Street Analyst Weigh In

Several research analysts have commented on the stock. Morgan Stanley decreased their price target on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a research note on Wednesday, May 14th. Royal Bank Of Canada decreased their price target on shares of UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 30th. TD Cowen cut UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 target price for the company. in a report on Monday, May 19th. Wolfe Research dropped their target price on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a report on Tuesday, May 20th. Finally, Baird R W cut UnitedHealth Group from a "hold" rating to a "strong sell" rating in a report on Thursday, July 31st. Fifteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company's stock. Based on data from MarketBeat, UnitedHealth Group has a consensus rating of "Moderate Buy" and an average target price of $367.71.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.